Shandong Weigao Group repurchases shares on Hong Kong Exchange

On November 18, 2025, Shandong Weigao Group Medical Polymer Company Limited repurchased 470,000 H shares on the Exchange. The shares were bought back at prices ranging from HK$5.28 to HK$5.4, with an aggregate price paid of HK$2,515,700. This transaction resulted in a 0.0105% reduction in the number of issued shares (excluding treasury shares) from the previous day's balance.

Following the repurchase, the company's closing balance of issued shares (excluding treasury shares) now stands at 4,496,748,724, while the number of treasury shares increased to 25,583,600. The total number of issued shares remains 4,522,332,324. All 470,000 repurchased shares are designated to be held as treasury shares, with none for cancellation.

The repurchase was conducted under a mandate granted on May 27, 2025, which authorized the repurchase of up to 451,560,392 shares. To date, the company has repurchased 18,935,200 shares on the Exchange, representing 4.1933% of the issued shares (excluding treasury shares) as of the mandate date. A moratorium on new share issues or treasury share sales is in effect until December 17, 2025.